Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2021-12-09 00:00:00 ET · period of report 2021-12-07 · accession 0001415889-21-005801 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-09 | 2021-12-07 | ANIP | Pera Antonio R | Dir | P - Purchase | $42.26 | +3,000 | 19.7K | +18% | +$126.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-07 | P | A | 3,000 | $42.26 | 19,713 | D | — | — | (F1) The shares were acquired in multiple trades at prices ranging from $42.24 to $42.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |